Skip to main content
. 2021 Feb 15;28(1):380–389. doi: 10.1080/10717544.2021.1883158

Figure 5.

Figure 5.

In vitro cellular uptake analysis results (a) CLSM observations of BCECs cells incubated with dm@MNP and dm@LMNP formulations; (b & c) flow cytometric analysis results of cellular uptake of dm@LMNP compared with other nanoformulations including control; (d) In vitro analysis of BBB crossing of dm@LMNP through transcytosis technique (n = 3, *p < .05, error bar indicates SD).